tiprankstipranks
Trending News
More News >
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
US Market

Larimar Therapeutics (LRMR) Income Statement

Compare
1,075 Followers

Larimar Therapeutics Income Statement

Last quarter (Q3 2025), Larimar Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Larimar Therapeutics's net income was $-47.71M. See Larimar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ -155.00K
Operating Expenses
$ 90.89M$ 41.76M$ 36.53M$ 50.47M$ 42.65M
Depreciation and Amortization
$ 318.00K$ 311.00K$ 318.00K$ 326.00K$ 155.00K
EBITDA
$ -90.57M$ -41.45M$ -36.21M$ -50.14M$ -42.65M
Operating Income
$ -90.89M$ -41.76M$ -36.53M$ -50.47M$ -42.80M
Other Income/Expenses
$ 10.29M$ 4.81M$ 1.17M$ -171.00K$ 322.00K
Pretax Income
$ -80.60M$ -36.95M$ -35.35M$ -50.64M$ -42.48M
Net Income
$ -80.60M$ -36.95M$ -35.35M$ -50.64M$ -42.33M
Per Share Metrics
Basic EPS
$ -1.32$ -0.84$ -1.33$ -2.93$ -3.56
Diluted EPS
$ -1.32$ -0.84$ -1.33$ -2.93$ -3.56
Weighted Average Shares Outstanding
61.26M 43.90M 25.76M 17.16M 11.88M
Weighted Average Shares Outstanding (Diluted)
61.26M 43.90M 25.76M 17.16M 11.88M
Currency in USD

Larimar Therapeutics Earnings and Revenue History